DNA recognition by lexitropsins, minor groove binding agents

Journal of Molecular Recognition

Volumn 7, Issue 2, 1994, Pages 79-88

  Lown, J William ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticancer; Antigene; DNA Groove bonding; Lexitropsins

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CONGOCIDINE; DISTAMYCIN A; DNA; DRUG DERIVATIVE; LEXITROPSIN; LIGAND;

ANIMAL; BINDING SITE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG DESIGN; ELECTROCHEMISTRY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; DISTAMYCINS; DNA; DRUG DESIGN; ELECTROCHEMISTRY; HUMAN; LIGANDS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; NETROPSIN; NUCLEIC ACID CONFORMATION; SUPPORT, NON-U.S. GOV'T;

EID: 0028449202     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.300070205     Document Type: Review

References (67)

1. DNA recogniton by intercalator‐minor groove binder hybrid molecules
2. Subcellular distribution of a nitroxide spin‐labeled netrospin in living KB cells: EPR and sequence specificity studies
3. Molecular recognition between ligands and nucleic acids: Novel pyridine and benzoxazole‐containing agents related to Hoechst 33258 that exhibit altered DNA sequence specificity deduced from footprinting analysis and spectroscopic studies
4. Netrospin and bisnetropsin analogs as inhibitors of the catalytic activity of Mammalian DNA topoisomerase II and topisomerase cleavable complexes
5. Effects of analogs of DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities
6. Chromosomal loop anchorage of the kappa immunoglobin gene occurs next to the enhancer in a region containing topoisomerase II Sites
7. Design of Sequence‐specific DNA‐binding molecules
8. The DNA helix and how it is read
9. Base sequence, helix structure and intrinsic information readout
10. Structure of a B‐DNA dodecamer of III geometry hydration
11. Design and binding of a distamycin A analog to d(CGCAAGTTGGC): d(GCCAACTTGCG) Synthesis, NMR structure and implications for the design of sequence specific minor groove binding oligopeptides
12. Metaphase chromosome structure. Involvement of topoisomerase II
13. NMR characterization of a heterocomplex formed by distamycin and its analog 2‐ImD with d[CGCAAGTTGGC]. d[GCCAACTTGGG]: The 1:11 hetero complex is favoured over either 2:1 hemocomplex
14. Isohelical analysis of DNA groove‐binding drugs
15. DNA sequence selective binding of head‐to‐tail linked lexitropsins: Relation of phasing to cytotoxic potency
16. 'Control of gene expression by oligodeoxynulceotides covalently linked to intercalating agents and nucleic acid‐cleaving agents
17. Oligodeoxynucleotides covalently linked to intercalating agents: A few class of gene regulatory substances
18. Inducible production of c‐fos antisense RNA inhibits 3T3 cell proliferation
19. Pyrrole‐(1,4)benzodiazepine antitumor antibiotics Relationship of DNA alkylation and sequence specificity to the biological activity of natural an synthetic compounds
20. Inhibition of thymidine kinase gene expression by antisense RNA: A molecular approach to genetic analysis
21. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding
22. Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis‐netrospin analogues deduced from footprinting analysis
23. The molecular origin of DNA‐drug specificity in netropsin and distamycin
24. Synthesis of novel imidazole‐containing DNA minor groove binding oligopeptides related to the antiviral antibiotic netropsin
25. Molecular recognition between oligopeptides and nucleuc acids‐rational design sequence specific DNA binding agents
26. 1H‐NMR evidence for thiazole intercalation
27. 1H‐NMR and molecular modeling study
28. Sequence specificity of actinomycin D and netropsin binding to pBR322 DNA analyzed by protection from DNas I
29. Synthesis of (4S) and (4R)‐methyl‐2‐amino‐1‐pyrroline‐5‐carboxylates and their application to the preparation of (4S) (+) (4R) (−) dihydrokikumycin
30. 1″
31. 1H‐NMR studies
32. Total synthesis and absoulte configuration of the antibiotics oligoepeptide (4S) (+) anthelvencin A and its (4R) (−) enantiomer
33. 1H‐NMR studies
34. Molecular recognition between oligopeptides and nucleic acids: Influence of van der Waals contacts in determining the 3′‐terminus of DNA sequences read by monocationic lexitrospins
35. 2
36. 1H‐NMR studies
37. 1H‐NMR, footprinting and thermodynamic data
38. 1H‐NMR footprinting studies and thermodynamic data
39. Lexitropsins: Rational design of DNA sequence reading agents as novel anticancer agents and potential cellular probes
40. Synthetic chemistry of naturally occurring oligopeptide antibiotics and related lexitropsins
41. Molecular mechanisms of DNA sequences recognition by groove binding ligands: Biochemical and biological consequences
42. Molecular recognition between oligopeptides and nucleic acids: Novel imidazole‐containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity
43. Inhibition of DNA binding protein by oligonucleotide‐directed triple helix formation
44. Control of ribonucleic acid function by oligonucleoside methyl phosphonates
45. Sequence‐selective DNA recognition by synthetic ligands
46. DNA conformations, dynamics and interactions in solution
47. Structural characterization of a 2:1 distamycin A.d(CGCAAATTGGC) complex by two‐dimensional NMR
48. DNA sequence specific recognition by a thiazole analogue of netropsin: A comparative footprinting study
49. Molecular mechanisms of specificity in DNA‐antitumor drug interactions
50. Mode of action of saframycin antitumor antibiotics: Sequence selectivities in the covalent binding of saframycines A and S to DNA
51. Synthesis of novel thiazole containing DNA minor groove binding oligopeptides related to the antibiotic distamycin
52. Molecular recognition between oligopeptides and nucleic acid: DNA sequence specificity and binding properties of thiazole‐lexitropsins incorporating the concepts of base site acceptance and avoidance
53. Molecular recognition between oligopeptides and nucleic acids: DNA binding selectivity of a series of 1,2,4‐triazole containing lexitrospins
54. Sequences selective DNA binding by linked bis‐N‐methylpyrrole dipeptides: an analysis by MPE footprinting and force field calculation
55. Reaction of the antitumor antibiotics CC‐1065 with DNA Location of the site of structurally induced strand breakage and analysis of DNA sequences specificity
56. DNA binding by proteins
57. 1H‐NMR study of the DNA binding characteristics of thioformyldistamycin, and amide isosteric lexitropsin
58. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide
59. Mechanisms of bleomycin‐induced DNA degradation
60. DNA binding proteins
61. Methidium‐propyl‐EDTA‐Fe(II) and DNase I footprinting report different small molecule binding site sizes on DNA
62. DNA minor groove binding agents interfere with topoisomerae II mediated lesions induced by epipodophyllotoxin derivative VM‐26 and acridine derivative m‐AMSA in nuclei from L 1210 cells
63. Sequence specific recognition of B‐DNA by oligo (N‐methylpyrrolecarboxamide)
64. Non‐intercalating DNA‐binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material
65. Effect of ligand structure on the dA.dT‐specific DNA groove binding of nonintercalating drugs
66. Amide isosteres of lexitropsins: Synthesis, DNA binding characteristics and sequence selectivity of thioformyldistamycin